We are monitoring the impact of COVID-19 on Insomnia Market Get in touch with us for detailed analysis Know More
Pulished Date October, 2020
ID: 10323
Share on
Share on

Global Insomnia Market Size, Share, Trends and Growth Analysis Report – Segmented By Therapy Type and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Industry Forecast (2020 to 2025)

Pulished: October, 2020
ID: 10323
Pages: 190

Insomnia Market Size (2020 To 2025)

The global insomnia market size is estimated to grow at a CAGR of 5.9% from 2020 to 2025.

The global insomnia market is predicted to expand during the forecast period due to the increasing pervasiveness of insomnia, the growing demand for its innovative therapy, the development of therapeutics with fewer side effects, and stressful work. Moreover, the acceleration in demand for OTC sleep aids is expected to offer promising growth opportunities in the market during the forecast period.

Patent expiration, side -effects of insomnia drugs, and lack of education and awareness among ordinary people are the key factors restraining the market growth.

Impact of COVID-19 on the global insomnia market

The COVID-19 pandemic has negatively affected many countries across the globe. Several measures introduced to deal with the pandemic, such as lockdowns, reduction in trade activities, and shutdown of multiple factories and workplaces in several countries, could save lives; however, these measures have wide-ranging economic effects inducing economic contagion. Along with the risk of a slowdown of global growth, the results of COVID-19 are adversely affecting various economic sectors in economies across the globe and has significantly impacted the global Insomnia Market. It is due to a disrupted supply chain and shift in focus to develop a vaccine for COVID-19. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Analysed

By Therapy Type and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

 

This research report on the global Insomnia Market has been segmented based on therapy type and region.

Insomnia Market - By Therapy Type:

  • Non-pharmacological therapy
    • Hypnotherapy
    • Cognitive Behavioral Therapy
    • Medical Devices
    • Other Non-pharmacological Therapy
  • Pharmacological Therapy
    • Prescription Sleep Aids
    • OTC Sleep Aids

Insomnia Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America led the insomnia market and valued 46% of the total revenue share in 2019. Increasing demand for sleep disorder therapy in the U.S. and Canada, coupled with an increasing pervasiveness of sleep disorders, an increase in information, and high healthcare expenditure is estimated to propel the market. Moreover, the high predominance of this disease among the geriatric population and the rapidly growing aging population in the U.S. is expected to be the key driving factor promoting demand. Good reimbursement plans for therapeutic products, a robust clinical pipeline, and rising stress levels are other factors anticipated to encourage revenue growth.

North America was followed by the Asia Pacific, which accounted for 20.9% of the total market revenue in 2019. Japan has a significant contribution to the market due to the high pervasiveness of target disease, and it is estimated that 20% of Japan's population suffers from the disorder. Developing economies such as India, China, and Indonesia have been using generics and branded generics due to generic alternatives' economical pricing. An increase in demand for new treatment options and rising prevalence is expected to drive growth during the forecast timeframe.

Asia Pacific is estimated to observe lucrative growth over the forecast period, with a 7.8% CAGR. Shift-work sleep disorder and increased stress levels are expected to expand the patient base in the Asia Pacific. These factors may add to the growing demand for drugs in these economies. Besides, continually improving healthcare reimbursement plans are expected to boost demand over the forecast period.

KEY PLAYERS IN THIS MARKET

Notable companies are playing a dominant role in the global Insomnia market profiled in this report Merck & Co., Mylan N.V., Paratek Pharmaceuticals, Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Ltd., Teva Pharmaceutical Industries Ltd., and Vanda Pharmaceuticals Inc.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. Therapy Type
      1. Non-pharmacological Therapy
        1. Hypnotherapy
        2. Cognitive Behavioral Therapy
        3. Medical Devices
        4. Other Non-pharmacological Therapy
      2. Pharmacological Therapy
        1. Prescription Sleep Aids
        2. OTC Sleep Aids
      3. Y-o-Y Growth Analysis, By Therapy Type
      4. Market Attractiveness Analysis, By Therapy Type
      5. Market Share Analysis, By Therapy Type
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Therapy Type
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Therapy Type
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Therapy Type
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Merck & Co.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Mylan N.V.
    3. Paratek Pharmaceuticals, Inc.
    4. Pfizer Inc.
    5. Sanofi S.A.
    6. Sumitomo Dainippon Pharma Co., Ltd.
    7. Takeda Pharmaceutical Company Ltd.
    8. Teva Pharmaceutical Industries Ltd.
    9. Vanda Pharmaceuticals Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Global, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of therapy type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Insomnia Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  3. Global Non-pharmacological therapy Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  6. Global Prescription Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  7. Global OTC Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  9. Global Hypnotherapy Market, By Region, From 2020 to 2025 (USD Million)
  10. Global Cognitive Behavioral Therapy Market, By Region, From 2020 to 2025 (USD Million)
  11. Global Medical Devices Market, By Region, From 2020 to 2025 (USD Million)
  12. Global Other Non-pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  13. North America Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  14. North America Non-pharmacological therapy Market, By Region, From 2020 to 2025 (USD Million)
  15. North America Pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  16. United States Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  17. Canada Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  18. North America Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  19. North America Prescription Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  20. North America OTC Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  21. United States Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  22. Canada Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  23. North America Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  24. North America Hypnotherapy Market, By Region, From 2020 to 2025 (USD Million)
  25. North America Cognitive Behavioral Therapy Market, By Region, From 2020 to 2025 (USD Million)
  26. North America Medical Devices Market, By Region, From 2020 to 2025 (USD Million)
  27. North America Other Non-pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  28. United States Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  29. Canada Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  30. Europe Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  31. Europe Non-pharmacological therapy Market, By Region, From 2020 to 2025 (USD Million)
  32. Europe Pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  33. U.K. Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  34. Germany Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  35. France Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  36. Italy Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  37. Spain Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  38. Europe Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  39. Europe Prescription Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  40. Europe OTC Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  41. U.K. Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  42. Germany Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  43. France Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  44. Italy Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  45. Spain Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  46. Europe Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  47. Europe Hypnotherapy Market, By Region, From 2020 to 2025 (USD Million)
  48. Europe Cognitive Behavioral Therapy Market, By Region, From 2020 to 2025 (USD Million)
  49. Europe Medical Devices Market, By Region, From 2020 to 2025 (USD Million)
  50. Europe Other Non-pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  51. U.K. Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  52. Germany Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  53. France Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  54. Italy Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  55. Spain Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  56. Asia Pacific Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  57. Asia Pacific Non-pharmacological therapy Market, By Region, From 2020 to 2025 (USD Million)
  58. Asia Pacific Pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  59. Japan Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  60. China Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  61. India Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  62. Australia Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  63. South Korea Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  64. Asia Pacific Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  65. Asia Pacific Prescription Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  66. Asia Pacific OTC Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  67. Japan Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  68. China Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  69. India Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  70. Australia Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  71. Asia Pacific Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  72. Asia Pacific Hypnotherapy Market, By Region, From 2020 to 2025 (USD Million)
  73. Asia Pacific Cognitive Behavioral Therapy Market, By Region, From 2020 to 2025 (USD Million)
  74. Asia Pacific Medical Devices Market, By Region, From 2020 to 2025 (USD Million)
  75. Asia Pacific Other Non-pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  76. Japan Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  77. China Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  78. India Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  79. Australia Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  80. Latin America Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  81. Latin America Non-pharmacological therapy Market, By Region, From 2020 to 2025 (USD Million)
  82. Latin America Pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  83. Brazil Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  84. Argentina Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  85. Mexico Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  86. Rest of Latin America Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  87. Latin America Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  88. Latin America Prescription Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  89. Latin America OTC Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  90. Brazil Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  91. Argentina Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  92. Mexico Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  93. Latin America Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  94. Latin America Hypnotherapy Market, By Region, From 2020 to 2025 (USD Million)
  95. Latin America Cognitive Behavioral Therapy Market, By Region, From 2020 to 2025 (USD Million)
  96. Latin America Medical Devices Market, By Region, From 2020 to 2025 (USD Million)
  97. Latin America Other Non-pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  98. Brazil Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  99. Argentina Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  100. Mexico Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  101. Middle East and Africa Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  102. Middle East and Africa Non-pharmacological therapy Market, By Region, From 2020 to 2025 (USD Million)
  103. Middle East and Africa Pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  104. Middle East Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  105. Africa Insomnia Market, By Therapy Type, From 2020 to 2025 (USD Million)
  106. Middle East and Africa Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  107. Middle East and Africa Prescription Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  108. Middle East and Africa OTC Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  109. Middle East Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  110. Africa Insomnia Market, By Pharmacological Therapy, From 2020 to 2025 (USD Million)
  111. Middle East and Africa Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  112. Middle East and Africa Hypnotherapy Market, By Region, From 2020 to 2025 (USD Million)
  113. Middle East and Africa Cognitive Behavioral Therapy Market, By Region, From 2020 to 2025 (USD Million)
  114. Middle East and Africa Medical Devices Market, By Region, From 2020 to 2025 (USD Million)
  115. Middle East and Africa Other Non-pharmacological Therapy Market, By Region, From 2020 to 2025 (USD Million)
  116. Middle East Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)
  117. Africa Insomnia Market, By Non-pharmacological therapy, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample